Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OLB Group Forms DMint, Inc. a Cryptocurrency Mining Company
New subsidiary will begin to mine Cryptocurrency in Q4 2021
NEW YORK--(BUSINESS WIRE)-- The OLB Group, Inc. (NASDAQ: OLB), a provider of cloud-based omnicommerce and payment acceptance solutions for small- and mid-sized merchants, announced the formation of DMint, Inc, a wholly-owned subsidiary of OLB (“DMint”) that will commence mining cryptocurrency in 2021. The operations plan for DMint to build out data centers and utilize ASIC machines to mine cryptocurrency with underutilized energy in accordance with ESG standards.
OLB’s Chief Executive Officer Ronny Yakov stated, “DMint will strategically enter the cryptocurrency mining business, using a cost efficient and green business model, which will significantly enhance OLB revenues. This new revenue source will also fuel new services and opportunities for our small- and medium-sized merchants.”
OLB Group believes that cryptocurrency will have a major impact in the payment industry and wants to be at the center of it. By starting our cryptocurrency mining subsidiary, OLB Group will be able to provide additional services to its existing merchant base.
For more information about The OLB Group, please visit www.olb.com or www.olb.com/investors-data.
https://www.otcmarkets.com/stock/OLB/news/story?e&id=1961028
Yes, thanks!
Filings out today
https://www.otcmarkets.com/stock/GSHN/disclosure
NEXT-ChemX is commercializing the Membrane Technology by setting up a pilot plant prototype to demonstrate the extraction of specific ions from solutions without using high pressure, temperature, or electrolysis in a more efficient, economical, and environmentally friendly manner. Novel Membrane Based Ion Extraction Technology; Our technology allows continuous transfer without high pressure, temperature or electrolysis as it mimics biological processes found in nature.
https://researchpark.illinois.edu/tenant_directory/next-chemx/
WWIN: Name/Symbol/CUSIP Change effective 7/30/21 , will change to Next-ChemX Corporation, CHMX
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
GPLB New 52-week High on decent volume.
Thanks for the info!
Yep, GPLB very quiet today.
Would be nice to finally have something here. Shaping up to be a nice day thus far.
Getting some volume today, most in 52-weeks.
CalEthos Issues CEO Business Update
TUSTIN, CA – July 20, 2021 — CalEthos, Inc. (OTC Markets: BUUZ.PNK) (“CalEthos” or the “Company”) today issued the following business update from Michael Campbell, Chairman and Chief Executive Officer:
To Our Fellow CalEthos Stakeholders:
Over the past few months, many notable changes have been made at CalEthos as we continued our efforts to create value for all CalEthos stakeholders. As most of you are aware, prior to the outbreak of the COVID-19 pandemic last year, we had intended to focus our business development efforts on building a chain of large-format cannabis superstores to serve the needs of the rapidly-growing Southern California cannabis market. However, over the past two years, financing for large-scale cannabis development projects has largely dried up, which caused us to review our company’s prospects and our ability to obtain financing and succeed in that industry. Fortunately, however, while we determined in late 2020 that the door for building a cannabis business was closing, we reconnected with a long-term business associate from the computer industry that was planning to develop a next generation high-performance computer system for processing crypto transactions. After much consideration, we made the decision to team up and transition the Company into developing and manufacturing transaction processing systems for cryptocurrency, tokens and blockchain applications.
On the basis of months of research of the crypto industry, we now plan to focus our business efforts on building a high-performance computer hardware business by developing a 5 nanometer ASIC chip and immersion-cooled bitcoin mining system for larger cryptocurrency mining companies. In connection with our change of business direction, we plan to change our corporate name to AIQ Blockchain, Inc. (“AIQ”) and our trading symbol, pending FINRA approval, to AIQB.QB. This will entail our filing of an Information Statement with the Securities and Exchange Commission relating to the corporate name change and an application with FINRA for the CUSIP change. In addition, in connection with such activities, we intend to file an application with OTC Markets Inc. to upgrade the trading market for our common stock to the OTCQB tier of the OTC Markets Inc.
In parallel with those efforts, we intend to hire a Chief Technology Officer, a technical support team, and a contract chip and systems engineering team to develop a 5 nanometer ASIC chip for bitcoin mining machines and an immersion-cooled bitcoin mining system that we plan to manufacture for larger bitcoin mining companies.
The ASIC chip and immersion-cooled system development is expected to take ten to 12 months to complete. At the final stages of development, we plan to complete prototypes for both ¼ and ½ MW immersion-cooled bitcoin mining systems for testing and customer demonstration. We are planning to design the systems to require over 50% less energy than conventional air-cooled bitcoin mining operations that currently make up over 90% of the global bitcoin mining fleet.
We intend to fund the development of our ASIC chips and immersion-cooled systems through equity or debt financings to accredited investors.
https://www.otcmarkets.com/filing/html?id=15099275&guid=U98kkeeRrRhA0th
BUUZ another filing out today. Getting close to current.
I pulled out a while ago. Good luck
IPEU another filing out today.
https://www.otcmarkets.com/stock/IPEU/disclosure
Yeah, been there as well.
Nope did not get any NOTR even in the .80s where I was bidding. Using worthless AON for bids with TDA.
Oops, forgot to mention that little piece of info...lol
Thanks
BUUZ another filing out today.
BRST nice bid in, 14K @ $3.75
BUUZ finally have some 10-Q filings today!
BRST $5 hit
BRST new tier OTCQX.
https://www.otcmarkets.com/stock/BRST/profile
Sorry, no.
NOTR been on my WL since August of last year. Checked for shares earlier, missed it.
Yes, patience is quite a virtue! Best of luck to all.
Nice! Been waiting for this FS.
IPEU filings hitting today.
https://www.otcmarkets.com/stock/IPEU/disclosure
Nice clean low float shell ready for a nice RM.
Agreed, hopefully very soon now.
BLYQ looking good!
Rapid Therapeutic Finalizes Lab Work on Pharmaceutical Formulas
DALLAS, June 10, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced today that it has concluded lab development on three (3) formulas related to manufacturing of pharmaceutical grade isolates used in both metered dose inhalers and other aerosol products.
RTSL has developed three (3) proprietary pharmaceutical formulas, two (2) for cannabidiol (CBD) and one (1) for cannabigerol (CBG), to initially be used in Metered Dose Inhalers (MDI). One CBD formula is expected to be used in testing of the MDI which the Company plans to submit to the U.S. Food and Drug Administration (FDA) in connection with an Investigational New Drug Application (IND), as previously announced. The other two are planned to be used in RTSL’s other products.
RTSL’s CEO, Donal R. Schmidt, Jr. stated, “We initially set out to find an ultra-pure, unadulterated pharmaceutical grade CBD isolate to use in our MDI. Early on we learned the purity level of an isolate is materially related to airway irritation and the level of cough reflex when using an MDI. We also learned CBD isolate is not chemically compatible with metered dose inhalers without significant modifications in the manufacturing process. In short, we were unsatisfied with any product we could source in the hemp space to meet our needs. As such, we set out to engineer a quality isolate to meet our needs.”
“With the purchase of Razor Jacket and the addition of Dr. Drinkwine, each as previously announced, we learned how to manufacture pharmaceutical grade isolate in-house. We believe our process is unique and will result in one or more patents being granted to RTSL. Once the patent applications have been filed, which are planned to be filed in the next few weeks, we expect to release the details of our findings, which we believe will make a significant impact in the hemp space related to isolate manufacturing.”
In conclusion, Mr. Schmidt stated, “At this point, as we head to market with other non-MDI products and while we are preparing to submit the IND, we believe we are well positioned as we have an ISO 6 certified aerosol filling lab, we are progressing well on our way to completion of our Good Manufacturing Process (GMP) certification, and we believe we have true pharmaceutical grade Active Pharmaceutical Ingredients (API).”
https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1919246
Yep. One step closer to getting current on filings.
Rapid Therapeutic Prepares to bring Sublingual Spray Products to Market
DALLAS, June 08, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced today it is preparing to launch a marketing and sales campaign of its recently enhanced sublingual spray line (which is applied via a spray into the mouth).
These sublingual sprays are made using RTSL’s proprietary pharmaceutical grade isolates in blends for multiple flavors and terpenes. In addition, the sprays are manufactured on the same exact equipment as RTSL’s metered dose inhalers (MDI), in the company’s existing ISO Level 6 laboratory, following Good Manufacturing Practice (GMP) standards.
RTSL’s CEO, Donal R. Schmidt, Jr. stated, “Our decision to file an IND application for our flagship MDI containing Cannabidiol (CBD), as previously announced, requires we remove this MDI product from the market while the application is pending. Nevertheless, this removal will not affect our use of pure pharmaceutical isolates formulas we have developed or our existing aerosol equipment. In fact, in addition to the sublingual sprays we are preparing to market, we are also testing nasal sprays and topical sprays, using our existing equipment and formulas for planned delivery in the fourth quarter.”
These products are expected to be sold both as branded products and on a white label basis in RTSL’s existing sales channels.
Mr. Schmidt continued, “Based upon discussions with our existing customers, as well as new contacts, we expect significant demand for these products. Although the bioavailability of a sublingual spray is generally not as high as an MDI, it nonetheless typically has higher bioavailability than oral pills and topicals. Regardless, when we discussed the availability of the sublingual spray products with our customers, almost all of them recognize that our specifically manufactured pharmaceutical grade isolates set us apart from other hemp product producers. In short, we have a non-toxic, pure isolate product that deliverers the exact dose each and every use.”
In conclusion, Mr. Schmidt observed that, “RTSL is branding itself as a biopharmaceutical outlier in the hemp space. We make pure products with pharmaceutical grade components on well proven aerosol equipment that delivers safe non-toxic products at known consistent dosage.”
https://www.otcmarkets.com/stock/RTSL/news/story?e&id=1916875
FORM 8-K Changes in Control of Registrant
David Lazar was appointed as the Company’s Chief Executive Officer, President, Secretary, Chief Financial Officer, Chief Executive Officer and Chairman of the Board of Directors.
https://www.otcmarkets.com/filing/html?id=15015519&guid=tpDUkp-bmiG5s3h
WOW! Congrats, Ask has been going crazy today.
Litchfield Hills Research Report Highlights Continued Positive Trends in Q1 2021 Results
West Palm Beach, FL, May 27, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, announced today, equity research firm, Litchfield Hills Research LLC, released its analyst coverage report on USAQ for first quarter 2021 results for the period ended March 31, 2021, rating the Company a "Buy" under its three-tiered (buy-hold-sell) rating system, with a target price of $5.00 per share.
As of the end of its last trading day, USAQ's shares closed at $.68 per share.
"Litchfield Hills research report highlights the strong sequential improvement in revenue and gross margin we saw in our first quarter financial results. We have made significant progress over the past few months with the commercial launch of AllergiEnd®’s allergy diagnostic and Allergen immunotherapy products expansion of our management team and visibility in the industry among primary care physicians. We continue to expect an increase in revenue and gross margin in the second quarter of 2021” said Troy Grogan, CEO of USA Equities Corp.
Litchfield Hills Research adheres to FINRA standards for quality and objectivity. The Litchfield Hills Research Department certifies its report is compliant with FINRA research rules 2241, 3110. Litchfield’s price target, financial models, peer comparisons, and investment thesis are developed without input from management of the company, and they perform their own USAQ due diligence.
The research report is MiFID II compliant and is classified as minor non-monetary benefit under MiFID II. It is accessible on Bloomberg, FactSet, NASDAQ, NYSE Connect, S&P Cap IQ, Thomson Reuters (Refinitiv) and 12 other platforms around the globe. It will be posted to the research firm’s website http://www.hillsresearch.com/current-research/
https://www.otcmarkets.com/stock/USAQ/news/story?e&id=1908356
Nice $9 hit today!
Hmmm what's going on today?
Daily List: KYNS Symbol/Name Change effective 05/19/2021
New symbol: IPEU
New name: IPE Universal Inc
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
SKFG up for grabs, MM GLED $0.06 x $1.01
https://www.otcmarkets.com/stock/SKFG/security